Inc.
-
Jul 04 2022Skye Bioscience gets Australian HREC nod to begin first-in-human phase 1 study of SBI-100 ophthalmic emulsion
Skye Bioscience, Inc., a pharmaceutical company developing a proprietary, synthetic…
Read more
